Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (41-50 of 4,096) with videos related to

Pageof 410
Sort By:
Cancer Cell|February 3, 2009
Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironmentMarcin Kortylewski, Hong Xin, Maciej Kujawski, et al.
Cancer Cell|November 16, 2010
Can antitumor immunity help to explain "oncogene addiction"?Nicholas P Restifo
Cancer Cell|November 16, 2010
STATistical power of clonal analysis: differential STAT1 pathway activation downstream of the JAK2V617F mutationAnn Mullally, Benjamin L Ebert
Cancer Cell|November 16, 2010
Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivationKe Liang, Francisco J Esteva, Constance Albarracin, et al.
Cancer Cell|November 16, 2010
Hdac3 is essential for the maintenance of chromatin structure and genome stabilitySrividya Bhaskara, Sarah K Knutson, Guochun Jiang, et al.
Cancer Cell|November 16, 2010
Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cellsKyoung Eun Lee, Dafna Bar-Sagi
Cancer Cell|November 16, 2010
B55β-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancerJing Tan, Puay Leng Lee, Zhimei Li, et al.
Cancer Cell|March 15, 2011
Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathwayEmmanuelle Godefroy, Olivier Manches, Brigitte Dréno, et al.
Cancer Cell|March 15, 2011
Twist1-induced invadopodia formation promotes tumor metastasisMark A Eckert, Thinzar M Lwin, Andrew T Chang, et al.
Cancer Cell|March 15, 2011
CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growthTakatsugu Ishimoto, Osamu Nagano, Toshifumi Yae, et al.
Pageof 410

Showing results (41-50 of 4,096) with videos related to

Sort By:
Pageof 410
Cancer Cell|February 3, 2009
Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironmentMarcin Kortylewski, Hong Xin, Maciej Kujawski, et al.
Cancer Cell|November 16, 2010
Can antitumor immunity help to explain "oncogene addiction"?Nicholas P Restifo
Cancer Cell|November 16, 2010
STATistical power of clonal analysis: differential STAT1 pathway activation downstream of the JAK2V617F mutationAnn Mullally, Benjamin L Ebert
Cancer Cell|November 16, 2010
Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivationKe Liang, Francisco J Esteva, Constance Albarracin, et al.
Cancer Cell|November 16, 2010
Hdac3 is essential for the maintenance of chromatin structure and genome stabilitySrividya Bhaskara, Sarah K Knutson, Guochun Jiang, et al.
Cancer Cell|November 16, 2010
Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cellsKyoung Eun Lee, Dafna Bar-Sagi
Cancer Cell|November 16, 2010
B55β-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancerJing Tan, Puay Leng Lee, Zhimei Li, et al.
Cancer Cell|March 15, 2011
Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathwayEmmanuelle Godefroy, Olivier Manches, Brigitte Dréno, et al.
Cancer Cell|March 15, 2011
Twist1-induced invadopodia formation promotes tumor metastasisMark A Eckert, Thinzar M Lwin, Andrew T Chang, et al.
Cancer Cell|March 15, 2011
CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growthTakatsugu Ishimoto, Osamu Nagano, Toshifumi Yae, et al.
Pageof 410